Unavailable Treatments

Following ongoing availability issues with Bettamousse 0.1% Cutaneous Foam (betamethasone valerate) we contacted RPH Pharmaceuticals AB, the manufacturer of Bettamousse, for an update in August 2019.

RPH confirmed that it is still in the process of transferring the manufacture of Bettamousse to a different site and with this comes the lengthy regulations and checking of the product before re-issue. According to the latest update, Bettamousse is now expected to be out of stock until at least September 2019.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0845 023 0467, or by email at customer.care@recipharm.com. 

In August 2019, we contacted Alliance Pharmaceuticals, manufacturer of the medicated scalp shampoo, Ceanel Concentrate, for an update on the availability of the product. They confirmed that Ceanel is currently out of production and they do not yet have a date for when it may return.

In the meantime, Alliance Pharma recommends that anyone affected by the unavailability of Ceanel Shampoo discusses suitable alternatives with their GP or Pharmacist.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01249 466 966, or by email at medinfo@alliancepharma.co.uk. 

In August 2019, we contacted Pierre Fabre Dermo-Cosmetique, the manufacturer of topical corticosteroid treatment, Clarelux foam, for an update on the availability of the product. They confirmed that, due to supply issues, they do not currently know when it will be back on the market again. The latest estimate is 2020.

There are no safety issues with the product so available stock can still be used.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 0208 731 3322, or by email at medicalinformation@pierre-fabre.co.uk.

Thornton and Ross Ltd have announced they are withdrawing Aquamol Emollient Cream from manufacture due to poor demand for the product. They told the Psoriasis Association 'the minimum volumes that we have to produce on a production run are far higher than demand and as such it wasn't viable to continue producing the product'.

If anyone has any questions, or would like to know more you can get in touch with the manufacturer directly either by phone on 01484 848 164, or by email at thorntonross@medinformation.co.uk.

We advise anyone affected by the discontinuation of Aquamol Emollient Cream to speak to their GP about alternative emollients that are available.

LEO Pharma has announced plans to phase out its Dovobet Gel (calcipotriol/betamethasone dipropionate gel) applicator from the beginning of summer 2019 in the UK, and autumn 2019 in Ireland, or earlier as and when existing stocks are depleted. This decision has been taken due to a lack of demand for the applicator. Please note that Dovobet Gel will remain available in bottles.

LEO apologises for any inconvenience caused by this product discontinuation, and recommends that anybody affected visits their healthcare professional to discuss their individual needs and preferences for the management of their psoriasis.

If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01844 347 333, or by email at medical-info.uk@leo-pharma.com if you are in the UK.

If you are based in Ireland, you can reach LEO Pharma's Medical Information team either by phone on +353 1 490 89, or by email at medical-info.ie@leo-pharma.com.